Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Continuous intravenous administration of live genetically modified salmonella typhimurium in patients with metastatic melanoma.

Literature DB >> 12616110

Continuous intravenous administration of live genetically modified salmonella typhimurium in patients with metastatic melanoma.

David M Heimann, Steven A Rosenberg.

Abstract

Entities: Disease Species

Mesh：

Substances：
Salmonella Vaccines

Year: 2003 PMID： 12616110 PMCID： PMC2656370 DOI： 10.1097/00002371-200303000-00011

Source DB: PubMed Journal: J Immunother ISSN： 1524-9557 Impact factor: 4.456

× No keyword cloud information.

1 in total

1. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma.

Authors: John F Toso; Vee J Gill; Patrick Hwu; Francesco M Marincola; Nicholas P Restifo; Douglas J Schwartzentruber; Richard M Sherry; Suzanne L Topalian; James C Yang; Frida Stock; Linda J Freezer; Kathleen E Morton; Claudia Seipp; Leah Haworth; Sharon Mavroukakis; Donald White; Susan MacDonald; John Mao; Mario Sznol; Steven A Rosenberg
Journal: J Clin Oncol Date: 2002-01-01 Impact factor: 44.544

1 in total

45 in total

1. A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy.

Authors: Kelly Flentie; Brandon Kocher; Seth T Gammon; Deborah V Novack; Jeffrey S McKinney; David Piwnica-Worms
Journal: Cancer Discov Date: 2012-05-03 Impact factor: 39.397

9. Salmonella enterica serovar Typhimurium immunotherapy for B-cell lymphoma induces broad anti-tumour immunity with therapeutic effect.

Authors: Sofía Grille; María Moreno; Thais Bascuas; Juan M Marqués; Natalia Muñoz; Daniela Lens; Jose A Chabalgoity
Journal: Immunology Date: 2014-11 Impact factor: 7.397

Review 10. Recent Progress in the Molecular Imaging of Tumor-Treating Bacteria.

Authors: Sae-Ryung Kang; Jung-Joon Min
Journal: Nucl Med Mol Imaging Date: 2021-01-31

Continuous intravenous administration of live genetically modified salmonella typhimurium in patients with metastatic melanoma.

1. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma.

1. A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy.

Review 2. Tumour-targeting bacteria engineered to fight cancer.

Review 3. Salmonella-allies in the fight against cancer.

Review 4. Anticancer effects of the microbiome and its products.

5. Motility is critical for effective distribution and accumulation of bacteria in tumor tissue.

6. Measuring growth and gene expression dynamics of tumor-targeted S. typhimurium bacteria.

Review 7. Engineering the perfect (bacterial) cancer therapy.

8. Programmable probiotics for detection of cancer in urine.

9. Salmonella enterica serovar Typhimurium immunotherapy for B-cell lymphoma induces broad anti-tumour immunity with therapeutic effect.

Review 10. Recent Progress in the Molecular Imaging of Tumor-Treating Bacteria.